lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells

lincROR influences the stemness and crizotinib resistance in EML–ALK+ non-small-cell lung cancer cells

Yonghua Yang,1,* Jingyu Huang,2,* Nianlin Xie,3,* Hu Huang,4,* Shaogan Xu,5 Jun Cai,1 Shuai Qi6 1Department of Oncology, First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China; 2Department of Thoracic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hub...

Full description

Bibliographic Details
Main Authors: Yang Y, Huang J, Xie N, Huang H, Xu S, Cai J, Qi S
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:OncoTargets and Therapy
Subjects:
EML-ALK
lincROR
stemness
crizotinib
NSCLC
Online Access:https://www.dovepress.com/lincror-influences-the-stemness-and-crizotinib-resistance-in-eml-alk-n-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/lincror-influences-the-stemness-and-crizotinib-resistance-in-eml-alk-n-peer-reviewed-article-OTT

Similar Items